Protein Foundry

Founded in 2015 and based in Madison, Wisconsin, Protein Foundry operates as a niche provider of research-grade recombinant chemokines and custom protein production services. Leveraging over two decades of specialized research, the company's core strength lies in its optimized molecular tools for producing functionally active chemokines, which are critical reagents for academic and industrial R&D in immunology and related fields. It generates revenue through direct sales of its catalog products and custom service contracts, positioning itself as a trusted supplier within the proteomics and synthetic biology research sectors. The company is privately held and led by academic scientists, blending deep domain expertise with a commercial focus.

Specialized molecular tools for the production and functional analysis of chemokines, with expertise in preserving native N-terminal sequences and capabilities in custom labeling and stable isotope labeling for structural biology applications.

Protein Foundry competes in the research reagents market against large vendors like Bio-Techne (R&D Systems) and PeproTech. It differentiates through deep specialization in chemokines, a focus on preserving native biological activity, and offering custom and high-end services like stable isotope labeling that larger players may not prioritize.